Gammar IV Interactions
There are 105 drugs known to interact with Gammar IV (immune globulin intravenous), along with 3 disease interactions. Of the total drug interactions, 85 are major, 19 are moderate, and 1 is minor.
- View all 105 medications that may interact with Gammar IV
- View Gammar IV disease interactions (3)
Most frequently checked interactions
View interaction reports for Gammar IV (immune globulin intravenous) and the medicines listed below.
- Aciphex (rabeprazole)
- Adenocard (adenosine)
- Advicor (lovastatin / niacin)
- albuterol
- alendronate
- Alka-Seltzer Original (aspirin/citric acid/sodium bicarbonate)
- Amikin (amikacin)
- Amoxil (amoxicillin)
- Aralen (chloroquine)
- Aristocort (triamcinolone)
- Astelin (azelastine nasal)
- Astepro (azelastine nasal)
- Atarax (hydroxyzine)
- Avelox (moxifloxacin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benzamycin (benzoyl peroxide / erythromycin topical)
- Bumex (bumetanide)
- Calcium 600 D (calcium / vitamin d)
- Ceclor (cefaclor)
- cephalexin
- chlorhexidine topical
- Cipro (ciprofloxacin)
- Clomid (clomiphene)
- Corticaine (hydrocortisone topical)
- Crestor (rosuvastatin)
- Culturelle DS (lactobacillus rhamnosus gg)
- Demadex (torsemide)
- Depo Provera (medroxyprogesterone)
- Desferal (deferoxamine)
- Symbicort (budesonide / formoterol)
Gammar IV disease interactions
There are 3 disease interactions with Gammar IV (immune globulin intravenous) which include:
More about Gammar IV (immune globulin intravenous)
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.